Skip to main content
  • twitter
  • facebook
  • linkedin
  • News & Media
  • Subscribe
  • Contact
Hit enter to search or ESC to close
Close Search
Enveric BiosciencesEnveric BiosciencesEnveric Biosciences
Menu
  • About Us
    • Company Overview
    • Team
    • Collaborations
    • Careers
  • Our Science
    • Psychedelic Therapies
    • CBD Combination Therapies
    • Development Programs
  • Investors
    • Investor Overview
    • Press Releases
    • Events + Presentations
    • Company Information
    • SEC Filings
    • Stock Information
    • Corporate Governance
    • News Alerts
Investors

Press Releases

Overview
Press Releases     
Events + Presentations
Company Information
Stock Information
SEC Filings
Corporate Governance
News Alerts

Recent Press Releases

Enveric Biosciences to Participate in Upcoming Conferences in June 2022
June 8, 2022
Enveric Biosciences to Participate in the Microdose Psychedelic Capital Conference on May 26, 2022
May 24, 2022
Enveric Biosciences to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022
May 17, 2022
Enveric Biosciences Announces Plans to Spin-off and Dividend its Cannabinoid Pipeline to Shareholders
May 11, 2022
Enveric Biosciences to Host Fireside Chat with Dr. Bob Dagher, Chief Medical Officer, on May 17th at 10:00 a.m. ET
May 5, 2022
Enveric Biosciences Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
May 3, 2022
View All Press Releases

Company

Science

Investors

News & Media

Contact

Sign Up for Updates

© 2022 Enveric Biosciences | Terms of Use | Privacy Policy

Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.

Close Menu
  • About Us
    • Company Overview
    • Team
    • Collaborations
    • Careers
  • Our Science
    • Psychedelic Therapies
    • CBD Combination Therapies
    • Development Programs
  • Investors
    • Investor Overview
    • Press Releases
    • Events + Presentations
    • Company Information
    • SEC Filings
    • Stock Information
    • Corporate Governance
    • News Alerts
  • News & Media
  • Subscribe
  • Contact